Lineage Cell Therapeutics
LCTX
#8704
Rank
A$0.21 B
Marketcap
$0.92
Share price
-8.32%
Change (1 day)
-44.49%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -A$33.88 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are A$8.71 Million. In 2023 the company made an earning of -A$39.82 Million a decrease over its 2022 earnings that were of -A$36.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$33.88 Million-14.91%
2023 -A$39.82 Million9.83%
2022 -A$36.25 Million-54.24%
2021 -A$79.22 Million86.07%
2020 -A$42.58 Million-31.97%
2019 -A$62.58 Million-5.42%
2018 -A$66.17 Million1.1%
2017 -A$65.45 Million-31.06%
2016 -A$94.93 Million-10.38%
2015 -A$0.11 Billion29.69%
2014 -A$81.68 Million31.68%
2013 -A$62.03 Million
2011 -A$30.1 Million89.78%
2010 -A$15.87 Million206.06%
2009 -A$5.19 Million-0.58%
2008 -A$5.22 Million164.89%
2007 -A$1.97 Million-30.22%
2006 -A$2.82 Million
2002 -A$3.28 Million-41.04%
2001 -A$5.56 Million-32.04%
2000 -A$8.18 Million-11.85%
1999 -A$9.28 Million
1997 -A$5.96 Million12.12%
1996 -A$5.32 Million106.25%
1995 -A$2.58 Million-11.11%
1994 -A$2.9 Million50%
1993 -A$1.94 Million20%
1992 -A$1.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion 528.66%๐Ÿ‡บ๐Ÿ‡ธ USA